BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30257140)

  • 41. Connexin 43-mediated bystander effect in two rat glioma cell models.
    Sanson M; Marcaud V; Robin E; Valéry C; Sturtz F; Zalc B
    Cancer Gene Ther; 2002 Feb; 9(2):149-55. PubMed ID: 11857032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential ganciclovir-mediated cell killing by glutamine 125 mutants of herpes simplex virus type 1 thymidine kinase.
    Drake RR; Wilbert TN; Hinds TA; Gilbert KM
    J Biol Chem; 1999 Dec; 274(52):37186-92. PubMed ID: 10601281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
    Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
    Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells.
    Beltinger C; Fulda S; Walczak H; Debatin KM
    Cancer Gene Ther; 2002 Apr; 9(4):372-81. PubMed ID: 11960288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.
    Denning C; Pitts JD
    Hum Gene Ther; 1997 Oct; 8(15):1825-35. PubMed ID: 9358032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.
    Matono S; Tanaka T; Sueyoshi S; Yamana H; Fujita H; Shirouzu K
    Int J Oncol; 2003 Nov; 23(5):1309-15. PubMed ID: 14532970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Enhancement of the bystander effect by tanshinone IIA in HSV-tK/GCV system is related to expression of connexin 43 mRNA].
    Huang GQ; Song Y; Zhang J; Lu YR; Xiao L; Yang Y; Guo YB
    Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):146-9. PubMed ID: 15196433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
    Robe PA; Princen F; Martin D; Malgrange B; Stevenaert A; Moonen G; Gielen J; Merville M; Bours V
    Biochem Pharmacol; 2000 Jul; 60(2):241-9. PubMed ID: 10825469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines.
    van Dillen IJ; Mulder NH; Sluiter WJ; Meijer C; de Jong S; Loncarek J; Mesnil M; de Vries EF; Vaalburg W; Hospers GA
    Oncol Res; 2005; 15(3):151-9. PubMed ID: 16050136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene.
    Asklund T; Appelskog IB; Ammerpohl O; Langmoen IA; Dilber MS; Aints A; Ekström TJ; Almqvist PM
    Exp Cell Res; 2003 Apr; 284(2):185-95. PubMed ID: 12651152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene.
    Cho HS; Lee HR; Kim MK
    J Korean Med Sci; 2004 Feb; 19(1):107-12. PubMed ID: 14966351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
    Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
    Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.
    Kuriyama S; Kikukawa M; Masui K; Okuda H; Nakatani T; Akahane T; Mitoro A; Tominaga K; Tsujinoue H; Yoshiji H; Okamoto S; Fukui H; Ikenaka K
    Int J Cancer; 1999 Oct; 83(3):374-80. PubMed ID: 10495430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.
    Estin D; Li M; Spray D; Wu JK
    Neurosurgery; 1999 Feb; 44(2):361-8; discussion 368-9. PubMed ID: 9932890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system.
    Zhang Z; Lin J; Chu J; Ma Y; Zeng S; Luo Q
    J Biomed Opt; 2008; 13(3):031209. PubMed ID: 18601533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.